ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 207 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $957,000 | -44.7% | 23,200 | -35.1% | 0.01% | -45.0% |
| Q2 2020 | $1,732,000 | +57.3% | 35,727 | +16.8% | 0.02% | +150.0% |
| Q3 2019 | $1,101,000 | +231.6% | 30,600 | +216.6% | 0.01% | +300.0% |
| Q1 2017 | $332,000 | -90.9% | 9,664 | -91.4% | 0.00% | -96.5% |
| Q2 2016 | $3,639,000 | +1077.7% | 112,100 | +1417.9% | 0.06% | +1800.0% |
| Q2 2015 | $309,000 | +53.0% | 7,385 | -11.0% | 0.00% | -57.1% |
| Q1 2014 | $202,000 | – | 8,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |